Category Archives: Cost of healthcare in the U.S.

American healthcare: no conscience, no empathy

KEY TAKEAWAY:  Vertex received approval for a new two-drug therapy called Orkambi, designed to treat 8,500 cystic fibrosis patients over the age of 12 who have the most common mutation for this disease. Vertex has priced this drug at $259,000 per patient annually and, not surprisingly, many are outraged. One patient said ““It’s egregious, this is more than five times the annual salary of the average American family. How can they in good conscience charge that much? Continue reading

Treating people, not conditions

More than one-third (35.7 percent) of adults are considered to be obese. More than 1 in 20 (6.3 percent) have extreme obesity. Almost 3 in 4 men (74 percent) are considered to be overweight or obese. The prevalence of obesity is similar for both men and women (about 36 percent).  In order to address this problem we need to treat the reasons behind obesity. Continue reading

Drug pricing and pharma: untold truths

KEY TAKEAWAY:  Pharma stocks lost over $24 billion in value after Mr Trump said drug prices are too high and the government needs to use a bidding system to determine the price of drugs.  The sell off in pharma stocks was because Wall Street has finally realized the “gravy train” is coming to an end. Continue reading

Older Americans paying the price for brand name prescription drugs

KEY TAKEAWAY:Retail prices for widely used brand name prescription drugs increased substantially faster than general inflation in every year from 2006 to 2015. Between 2014 and 2015, retail prices for 268 brand name prescription drugs widely used by older Americans, including Medicare beneficiaries, increased by an average of 15.5 percent. In contrast, the general inflation rate was 0.1 percent over the same period. Continue reading